Studies have confirmed that the immune components and functions of primary and metastatic renal cell carcinoma roughly overlap [28], however, the higher expression of PD-L1 and a lower CD8 to Foxp3 T cell ratio were found in metastatic lesions compared with matched primary tumor tissue [29]. The gene discussed is CD8A; the disease is neoplasm.